Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent progress and applications of small molecule inhibitors of Keap1–Nrf2 axis for neurodegenerative diseases
Jing Wang, Yu Cao, Lu Yang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 115998-115998
Closed Access | Times Cited: 19

Showing 19 citing articles:

Expanding the ligand spaces for E3 ligases for the design of protein degraders
Rahman Shah Zaib Saleem, Martin P. Schwalm, Stefan Knapp
Bioorganic & Medicinal Chemistry (2024) Vol. 105, pp. 117718-117718
Open Access | Times Cited: 9
Emodin, a Potent Anthraquinone Mitigates MPTP-Induced Parkinsons’ Disease Pathology by Regulating Nrf2 and Its Downstream Targets: In Silico and In Vivo Approach
Sarwat Jahan, Muhammad Ikram, Sami Siraj, et al.
Molecular Neurobiology (2025)
Closed Access | Times Cited: 1
Pharmacotherapeutic strategies for Friedreich Ataxia: a review of the available data
K.H. Günther, David R. Lynch
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 5, pp. 529-539
Closed Access | Times Cited: 7
Design, synthesis and biological evaluation of glucose metabolism inhibitors as anticancer agents
Yao Cheng, John P. Jones, Tsz Tin Yu, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107665-107665
Open Access | Times Cited: 4
Patenting perspective on Keap1 inhibitors (2019-2024)
Yue Luo, Wenlong Yang, Yuan Zhang, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Design and synthesis of novel cyclohexanecarboxamides with anticonvulsant effect by activating Nrf2-ARE pathway
Walaa Hamada Abd‐Allah, Mohammed S. Abdel‐Maksoud, Marawan A. Elbaset, et al.
Bioorganic Chemistry (2025) Vol. 159, pp. 108357-108357
Closed Access
Green procedures for synthesizing potential hNMDA receptor allosteric modulators through reduction and one-pot reductive acetylation of nitro(hetero)arenes using a superparamagnetic Fe3O4@APTMS@Cp2ZrClx (x = 0, 1, 2) nanocatalyst
Hossein Mousavi, Behzad Zeynizadeh, Farhad Sepehraddin
Nanoscale Advances (2025)
Open Access
Redox homeostasis and inflammation in fibroblasts of patients with Friedreich Ataxia: a possible cross talk
Andrea Quatrana, Sara Petrillo, Caterina Torda, et al.
Frontiers in Molecular Neuroscience (2025) Vol. 18
Open Access
Preclinical Research on Cinnamic Acid Derivatives for the Prevention of Liver Damage: Promising Therapies for Liver Diseases
Liseth Rubí Aldaba-Muruato, Brayan Escalante-Hipólito, Aldo Yoshio Alarcón-López, et al.
Biomedicines (2025) Vol. 13, Iss. 5, pp. 1094-1094
Open Access
A non-bactericidal cathelicidin with antioxidant properties ameliorates UVB-induced mouse skin photoaging via intracellular ROS scavenging and Keap1/Nrf2 pathway activation
Guizhu Feng, Qian Chen, Jin Liu, et al.
Free Radical Biology and Medicine (2024) Vol. 224, pp. 144-161
Closed Access | Times Cited: 3
Discovery and Optimization of a Series of Vinyl Sulfoximine-Based Analogues as Potent Nrf2 Activators for the Treatment of Multiple Sclerosis
Yoowon Kim, Jaehwan Kim, Byungeun Kim, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 2
Discovery of novel 5-phenyl-1H-pyrrole-2-carboxylic acids as Keap1-Nrf2 inhibitors for acute lung injury treatment
Jiaqin Tang, Xin Tie, Shumeng Zhi, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107741-107741
Closed Access | Times Cited: 1
Microbiome–Metabolomics Analysis Insight into the Effects of Starvation and Refeeding on Intestinal Integrity in the Juvenile Largemouth Bass (Micropterus salmoides)
Zhenxin Zhao, Xianbo Zhang, Fei Zhao, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12500-12500
Open Access | Times Cited: 1
Should We Consider Neurodegeneration by Itself or in a Triangulation with Neuroinflammation and Demyelination? The Example of Multiple Sclerosis and Beyond
Océane Perdaens, Vincent Van Pesch
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12637-12637
Open Access | Times Cited: 1
Redefining Neurodegenerative Treatment: Synergy of KEAP1, PROTACs, and Inflammatory Modulators
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 2, pp. 167-168
Closed Access
Exploring the therapeutic potential of Chinese herbs on comorbid type 2 diabetes mellitus and Parkinson's disease: A mechanistic study
Yan Wang, Peng-Peng Gao, Zicong Wu, et al.
Journal of Ethnopharmacology (2024) Vol. 338, pp. 119095-119095
Closed Access
Two turtle-derived tripeptides as ARE-luciferase inducers suppress H2O2-induced oxidative stress
Shilei Wang, Jianchang Jin, Yi Wu, et al.
Journal of Functional Foods (2024) Vol. 123, pp. 106606-106606
Open Access
Plant-Derived Nrf2 Activators to Enhance Liver Antioxidative and Regenerative Potentials
Tong-Xuan Tee, Li Ting Kee, Tsun‐Thai Chai, et al.
Revista Brasileira de Farmacognosia (2024)
Closed Access
Dimethyl fumarate alleviates Staphylococcus pseudintermedius-induced cell damage by inhibiting pyroptosis and bacterial virulence
Zhihao Wang, Long Guo, Pengfei Dong, et al.
Experimental Eye Research (2024), pp. 110210-110210
Closed Access
Page 1

Scroll to top